Literature DB >> 1429004

Cellular heterogeneity in human transitional cell carcinoma: an analysis of optical properties and lectin binding.

G K Ward1, S S Stewart, G Dotsikas, G B Price, W J Mackillop.   

Abstract

Flow cytometry was used to measure the binding of a panel of ten fluorescein isothiocyanate(FITC)-conjugated lectins to fifteen samples of normal and neoplastic human urothelium. Concurrent measurement of light scattering and fluorescence permitted the quantification of lectin binding to cellular subpopulations defined by their light-scattering properties. In normal urothelium, we previously demonstrated levels of lectin binding to the cellular subpopulations derived from the superficial and intermediate cell layers which were higher than levels which bound to the subpopulation derived from the basal cell layer (Ward et al., 1987). This difference was most marked with Maclura pomifera agglutinin (MPA), Ricinus communis agglutinin (RCA) and Ulex europeus agglutinin (UEA). We now report a similar correlation between the degree of differentiation of a cellular subpopulation and the level of lectin binding in human transitional cell carcinomas (TCCs). Morphological differentiation in human TCCs is accompanied by alterations in cell-surface carbohydrates which are similar to those which accompany cellular differentiation in the corresponding normal tissue. No systematic difference in lectin binding was observed between the corresponding subpopulations of normal and neoplastic urothelial cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429004     DOI: 10.1007/bf01047590

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  16 in total

1.  Light scattering properties of pluripotent and committed haemopoietic stem cells.

Authors:  G van den Engh; J Visser
Journal:  Acta Haematol       Date:  1979       Impact factor: 2.195

2.  Blood group ABO and Lewis antigens in fetal and normal adult bladder urothelium: immunohistochemical study of type 1 chain structures.

Authors:  T F Orntoft; H Wolf; H Clausen; S Hakomori; E Dabelsteen
Journal:  J Urol       Date:  1987-07       Impact factor: 7.450

3.  Cellular heterogeneity in normal human urothelium: an analysis of optical properties and lectin binding.

Authors:  G K Ward; S S Stewart; G B Price; W J Mackillop
Journal:  J Histochem Cytochem       Date:  1986-07       Impact factor: 2.479

4.  Realtime acquisition, storage, and display of correlated three-parameter flow cytometric data.

Authors:  S S Stewart; G B Price
Journal:  Cytometry       Date:  1986-01

5.  Early immunologic diagnosis and prognosis of carcinoma. Philip Levine Award Address.

Authors:  I Davidsohn
Journal:  Am J Clin Pathol       Date:  1972-06       Impact factor: 2.493

6.  Blood group isoantigens and bladder cancer. An overview.

Authors:  V Srinivas; S A Khan
Journal:  Urol Int       Date:  1985       Impact factor: 2.089

Review 7.  Tumor-associated carbohydrate antigens.

Authors:  S Hakomori
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

8.  Proliferation and ultrastructure of papillary transitional cell carcinoma of the human bladder.

Authors:  M J Fulker; E H Cooper; T Tanaka
Journal:  Cancer       Date:  1971-01       Impact factor: 6.860

9.  Multiangle light scattering flow photometry of cultured human fibroblasts: comparison of normal cells with a mutant line containing cytoplasmic inclusions.

Authors:  I A Schafer; A M Jamieson; M Petrelli; B J Price; G C Salzman
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

10.  Cellular heterogeneity in normal and neoplastic human urothelium.

Authors:  W J Mackillop; J P Bizarri; G K Ward
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

View more
  1 in total

1.  Characterization of lectins and their specificity in carcinomas-An appraisal.

Authors:  Asma Farhat Sherwani; Sameena Mohmood; Fauzia Khan; Rizwan Hasan Khan; Md Asim Azfer
Journal:  Indian J Clin Biochem       Date:  2003-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.